comparemela.com

Latest Breaking News On - Kiniksa pharmaceuticals stock down - Page 1 : comparemela.com

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sanjk-patel
Kiniksa-pharmaceuticals
Altitude-crest-partners-inc
Jpmorgan-chase-co
Kiniksa-pharmaceuticals-ltd
Peregrine-capital-management
Parkman-healthcare-partners
Kiniksa-pharmaceuticals-stock-down
Connor-clark-lunn-investment-management-ltd
Wells-fargo-company
Granahan-investment-management

Q1 2025 Earnings Estimate for Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Issued By Wedbush

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Stock analysts at Wedbush issued their Q1 2025 EPS estimates for Kiniksa Pharmaceuticals in a research report issued on Wednesday, February 28th. Wedbush analyst D. Nierengarten forecasts that the company will post earnings per share of ($0.17) for the quarter. Wedbush currently has a “Outperform” rating and […]

Johnf-paolini
Michaelr-megna
Kiniksa-pharmaceuticals-stock-down
Securities-exchange-commission
Kiniksa-pharmaceuticals
Blackrock-inc
Vanguard-group-inc
News-ratings-for-kiniksa-pharmaceuticals-daily
Kiniksa-pharmaceuticals-ltd
Morgan-stanley
Nasdaq

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Up to $20.89

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $20.89, but opened at $21.92. Kiniksa Pharmaceuticals shares last traded at $19.81, with a volume of 99,193 shares changing hands. Analyst Ratings Changes Several analysts have recently issued reports on […]

Johnf-paolini
Michaelr-megna
News-ratings-for-kiniksa-pharmaceuticals-daily
Goldman-sachs-group-inc
Nasdaq
Kiniksa-pharmaceuticals-ltd
Institutional-investors-weigh-in-on-kiniksa-pharmaceuticals
Securities-exchange-commission
Kiniksa-pharmaceuticals-stock-down
Altitude-crest-partners-inc
Kiniksa-pharmaceuticals

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Up to $20.89

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) shares gapped up before the market opened on Wednesday . The stock had previously closed at $20.89, but opened at $21.92. Kiniksa Pharmaceuticals shares last traded at $19.81, with a volume of 99,193 shares. Analysts Set New Price Targets KNSA has been the topic of several analyst […]

Johnf-paolini
Michaelr-megna
News-ratings-for-kiniksa-pharmaceuticals-daily
Group-plc
Nasdaq
Mercer-global-advisors-inc
Opaleye-management-inc
Kiniksa-pharmaceuticals-ltd
Parkman-healthcare-partners
Securities-exchange-commission
Institutional-trading-of-kiniksa-pharmaceuticals

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Price Down 2.9%

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) fell 2.9% during mid-day trading on Friday . The stock traded as low as $16.60 and last traded at $16.65. 45,947 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 431,343 shares. The stock had previously closed at $17.14. Kiniksa […]

Johnf-paolini
Kiniksa-pharmaceuticals-company-profile
Sphera-funds-management
Kiniksa-pharmaceuticals-stock-down
Nasdaq
Kiniksa-pharmaceuticals-ltd
Goldman-sachs-group-inc
Securities-exchange-commission
News-ratings-for-kiniksa-pharmaceuticals-daily
Kiniksa-pharmaceuticals
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.